research and development

Showing 15 posts of 209 posts found.

Sten Westerberg joins BioInvent

April 26, 2011
Research and Development appointment, research and development, sales and marketing

Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …

Trevor Smith to lead Takeda in Europe

April 21, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …

Novavax appoints Stanley Erck chief executive

April 20, 2011
Research and Development appointment, research and development

US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …

Angela Pasma to lead Chiltern’s new Netherlands office

April 1, 2011
Research and Development appointment, chiltern, research and development

Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …

Roche appoints Janet Hammond to translational medicine role

March 31, 2011
Research and Development appointment, research and development

Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …

aquapharm_bertrand_lehuu

Bertrand Lehuu joins Aquapharm

March 24, 2011
Research and Development appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …

efpia_lif_richard_bergstrom

Richard Bergström takes DG role at EFPIA

March 18, 2011
Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing

European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …

Former Gates Foundation director joins Sanofi

March 14, 2011
Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development

Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …

Francois Meyer to head up TxCell

March 9, 2011
Research and Development Francois Meyer, TxCell, appointment, research and development

French biotech TxCell has appointed François Meyer as chief executive. He has more than 25 years of pharma and biotech …

brecon_kay_ohagan

Boehringer’s Kay O’Hagan moves to Brecon

March 2, 2011
Manufacturing and Production, Research and Development Brecon, Kay O'Hagan, appointment, manufacturing and production, research and development

Kay O’Hagan has joined commercial packaging and clinical trials supply services company Brecon Pharmaceuticals as director of quality assurance and …

Friedhelm Felten to head procurement at Merck

March 1, 2011
Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …

Service Insight: Discovery metrics – creating the right balance

February 28, 2011
Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development

SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …

viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011
Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.

Pfizer research Sandwich, Kent

MPs to question Pfizer management over R&D closure

February 25, 2011
Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …

ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

February 23, 2011
Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …

The Gateway to Local Adoption Series

Latest content